Arca
Skip to content
Tools
Tools

Voltage-gated potassium channel

Family in Homo sapiens that 5 drugs act on.

  • Drugs that act on it: 5
  • Approved: 3
  • In phases 1 to 3: 2
  • Sponsors: 5
  • Genes: 40

Who is on it, and how far along

Every drug ChEMBL records acting on KCNA1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 5

Approved3

  • Guanidine
  • Dalfampridine
  • Amifampridine

Phase 31

  • Tedisamil

Phase 21

  • Nerispirdine

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Voltage-gated potassium channel blocker.
    GuanidineApprovedMerck & Co. (MSD)Small moleculeBlocker298
    DalfampridineApprovedMerz GroupSmall moleculeBlocker13
    AmifampridineApprovedCatalyst PharmaceuticalsSmall moleculeBlocker0
    TedisamilPhase 3SolvaySmall moleculeBlocker0
    NerispirdinePhase 2SanofiSmall moleculeBlocker0

    Open trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 16 in all, from ClinicalTrials.gov.
    Henagliflozin on Myocardial Fibrosis in Obese PatientsGuanidineNot applicableNot yet recruitingJing MaNov 19, 2026
    Efficacy of Topical Metformin 30% Versus Minoxidil 5% in the Treatment of Alopecia Areata : Comparative StudyGuanidineNot applicableRecruitingSohag UniversityNov 19, 2026
    An Evaluation of the Potential for VH4011499 Drug-drug-interactionsGuanidinePhase 1Not yet recruitingViiV HealthcareNov 16, 2026
    Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 DiabetesGuanidinePhase 4Not yet recruitingAllied Hospital FaisalabadNov 16, 2026
    Effects of Creatine Formulations on Exercise and Cognitive PerformanceGuanidineNot applicableRecruitingUniversity of Northern IowaNov 16, 2026
    Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin TherapyGuanidinePhase 2Not yet recruitingBeijing Supreme Life Pharmaceutical Technology Co., Ltd.Nov 10, 2026
    Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCIDalfampridineNot applicableRecruitingTryAbility LLCNov 6, 2026
    Aquatic Power Training Dosing Strategies and Creatine Supplementation in Older AdultsGuanidineNot applicableRecruitingUniversity of ValenciaNov 3, 2026
    Creatine and Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation Plus Home-Based Exercise for Sarcopenia in Huntington's DiseaseGuanidineNot applicableNot yet recruitingUniversidad de BurgosOct 28, 2026
    Single Dose 4-Aminopyridine for Diagnosing Recurrent Laryngeal Nerve Paralysis Continuity After TraumaDalfampridinePhase 1Not yet recruitingMilton S. Hershey Medical CenterSep 21, 2026
    The Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine UsersDalfampridineNot applicableRecruitingBoris QuednowApr 16, 2026
    A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 GeneDalfampridinePhase 3RecruitingAssistance Publique - Hôpitaux de ParisSep 22, 2025
    Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal TumorDalfampridinePhase 1RecruitingUniversity of California, San DiegoSep 12, 2025
    Double Dose 4-AP on Functional Recovery After Spinal Cord InjuryDalfampridinePhase 1 / Phase 2RecruitingShirley Ryan AbilityLabFeb 28, 2025
    Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate DepressionDalfampridinePhase 2RecruitingUniversity of BaselDec 30, 2024
    4-Aminopyridine to Treat Skin BurnsDalfampridinePhase 2RecruitingJohn ElfarSep 19, 2024

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2362996, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.